Literature DB >> 19069159

[Current knowledge on the genetic factors involved in moyamoya disease].

Hirokuni Hashikata1, Wanyang Liu, Yohei Mineharu, Kayoko Inoue, Katsunobu Takenaka, Hidetoshi Ikeda, Kiyohiro Houkin, Satoshi Kuroda, Kenji Kikuchi, Mitsuru Kimura, Takuyuu Taki, Makoto Sonobe, Sadahiko Ban, Hidekazu Nogaki, Akira Handa, Kenichiro Kikuta, Yasushi Takagi, Kazuhiko Nozaki, Nobuo Hashimoto, Akio Koizumi.   

Abstract

Moyamoya disease (MMD) is characterized by progressive stenosis and occlusion of the terminal portion of the bilateral carotid arteries as well as arterial collateral vessels. The etiology of MMD, however, remains unknown. Several pieces of evidence suggest the involvement of genetic factors in MMD: over 10% of MMD patients have affected blood relatives; concordance in the affection status has been proven in 80% of identical twins; and there is an ethnic predisposition to MMD, the incidence of the disease being the highest in the Asian population. With regard to genetic factor (s), transmission of MMD does not follow the classic Mendelian law, i.e., skipping of a generation and discordance in identical twins, thereby indicating that genetic influence is likely to determine the susceptibility to MMD. This study aimed to overview the recent findings related to the genetic determinants in MMD and to provide research perspectives for the next decade. Pathophysiological investigations at molecular levels have uncovered the upregulation of various growth and stress response factors that are associated with angiogenesis in occlusive cerebral arteries.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 19069159

Source DB:  PubMed          Journal:  Brain Nerve        ISSN: 1881-6096


  2 in total

1.  Association of HLA-DR and -DQ Genes with Familial Moyamoya Disease in Koreans.

Authors:  Seok Ho Hong; Kyu-Chang Wang; Seung-Ki Kim; Byung-Kyu Cho; Myoung Hee Park
Journal:  J Korean Neurosurg Soc       Date:  2009-12-31

2.  Clinical efficacy of extracranial-intracranial bypass for the treatment of adult patients with moyamoya disease: A protocol of systematic review of randomized controlled trials.

Authors:  Jun Yang; Guang-Fu Song; Hong-Bin Li; Shi-Hua Zhang; Fu-Yi Yang
Journal:  Medicine (Baltimore)       Date:  2019-12       Impact factor: 1.889

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.